Effectiveness of elbasvir and grazoprevir combination, with or without ribavirin, for treatment-experienced patients with chronic hepatitis C infection | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Effectiveness of elbasvir and grazoprevir combination, with or without ribavirin, for treatment-experienced patients with chronic hepatitis C infection

Kwo PY, Gane EJ, Peng CY, Pearlman B, Vierling JM, Serfaty L, et al. Effectiveness of elbasvir and grazoprevir combination, with or without ribavirin, for treatment-experienced patients with chronic hepatitis C infection. Gastroenterology. 2017;152(1):164-175.e4.

Publication Type:

Journal Article

Authors:

P Y Kwo; E J Gane; Peng, CY.; Pearlman, B.; Vierling, JM.; Serfaty, L.; Buti, M.; Shafran, S.; Stryszak, P.; Lin, L.; Gress, J.; Black, S.; Dutko, FJ.; Robertson, M.; Wahl, J.; Lupinacci, L.; Barr, E.; Haber, B.

Source:

Gastroenterology, Volume 152, Issue 1, p.164-175.e4 (2017)

Notes:

PubMed PMID: 27720838

Cited On:

Export Citation:

RIS Format

Top